FLS vs XYL: Which Is the Better Buy in 2026?

Same yardstick, side by side (as of September 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. FLS and XYL share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined FLS and XYL exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Flowserve Corporation is one of the world's largest suppliers of flow-control equipment. It designs, makes, and services pumps, valves, actuators, and mechanical seals used to move and control liquids and gases in demanding industrial settings. The business runs through two segments: Flowserve Pumps and Engineered Solutions (its larger unit, including seals) and Flow Control (valves and automation). A defining feature is its large installed base, which drives a high-margin aftermarket business of spare parts, repairs, and service that generates recurring revenue even when new-project orders slow. Its end markets skew to oil and gas, chemicals, general industries, power generation, and increasingly water.

Full FLS guide

Xylem was spun out of ITT in 2011 and has become the largest publicly traded pure-play water technology company, operating through four segments: Water Infrastructure (transport and treatment for utilities), Applied Water (pumps and equipment for building and industrial use), Measurement and Control Solutions (smart meters, sensors and the Sensus platform), and Water Solutions and Services (the outsourced treatment and services business built up by the 2023 Evoqua acquisition). Its customers are heavily weighted toward water and wastewater utilities plus industrial users, which gives it exposure to non-discretionary, regulation-driven spending on aging pipes, leak detection, metering and treatment.

Full XYL guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• FLS drivers: Aftermarket and installed base; 3D growth strategy and new end markets.
• XYL drivers: Aging infrastructure and water scarcity; Digital water and smart metering.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Flowserve's orders are cyclical and tied to capital spending in oil and gas, chemicals, and power, which can fall sharply when commodity prices or industrial demand weaken. For XYL, organic growth has been flat in recent quarters even as reported revenue grew, so the premium valuation leaves little room for disappointment if utility or industrial demand slows.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick FLS if you believe its drivers more; XYL if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the FLS and XYL guides.

FLS. Flowserve trades as a mid-cap industrial at roughly 18 times normalized earnings and around 1.9 times sales, valuations that embed expectations for margin expansion and its 3D growth push. The Chart merger termination left the balance sheet flush, with cash near $792 million reported in early 2026. Figures are approximate and as of July 2026; actual results move with each quarterly report.

XYL. Xylem generates roughly $9 billion in annual revenue and beat expectations in Q1 2026, delivering about $2.1 billion of revenue and around $1.12 in adjusted EPS while raising full-year guidance to a midpoint near $9.25 billion. At a market cap around $28 billion and a trailing P/E in the mid-30s, the stock trades at a premium to the broader industrials group, reflecting its pure-play water exposure and margin trajectory. Organic growth was roughly flat in the quarter even as reported revenue rose, so valuation leans on continued margin expansion.

Headline figures (approximate, July 2026): FLS shows revenue (fy2025) ~$4.7 billion, revenue (q1 2026) ~$1.07 billion (down ~7% YoY), adjusted eps (fy2025) ~$3.64, backlog (year-end 2025) ~$2.9 billion; XYL shows revenue (ttm) ~$9.1B, q1 2026 revenue ~$2.1B, 2026 revenue guidance (midpoint) ~$9.25B, q1 2026 adjusted eps ~$1.12.

FLS and XYL are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined FLS and XYL exposure against your real portfolio. It is not an investment adviser.